Medically reviewed by Paria Sanaty Zadeh, PharmD Attention-deficit/hyperactivity disorder (ADHD) medications can be ...

The U.S. Food and Drug Administration is revising the labeling of all extended-release attention-deficit/hyperactivity ...

Hundreds of thousands of Australians who use a certain type of ADHD medication will be forced to use amphetamine-based ...

The combined use of selective serotonin reuptake inhibitors and methylphenidate did not significantly increase adverse event risk among adults with ADHD and comorbid depression, according to a ...

Methylphenidate has a possibility to interact with more drugs. These interactions are harmful. Drug interactions can be prevented by avoiding unwanted drug combinations.

Methylphenidate (Ritalin, MPH) is a psychostimulant drug approved for treatment of attention-deficit hyperactivity disorder, postural orthostatic tachycardia syndrome and narcolepsy.It may also be ...

This has been methylphenidate versus placebo for treating fatigue in people with advanced cancer, randomized, double-blind, multicenter, placebo-controlled clinical trial. And again, this is a dual ...

Stanford University researchers have discovered why some people with attention deficit hyperactivity disorder may do well on their medicine for a while but struggle down the road.

Citation: A single dose of methylphenidate does not affect the contextual visual perception of children with ADHD, shows study (2023, February 23) retrieved 24 May 2025 from https://medicalxpress ...

D’Aiello B, Gessi L, Menghini D, Vicari S, De Rossi P. Sleep disturbances in children with ADHD on methylphenidate monotherapy: the role of dysregulation profile. Sleep Med . 2025:128:153-158 ...